Haselmeier

Haselmeier, operating as the drug delivery device business of medmix, is a globally established player in the medical device sector focused on innovative self-injection systems. The company leverages world-class manufacturing facilities across the EU, USA, and India to deliver a full spectrum of services from product development and human factors engineering to regulatory support and commercial-scale manufacturing. Its core value proposition lies in combining deep technical expertise in device platforms like autoinjectors and injection pens with a comprehensive, client-partnered approach to bring cost-effective, safe, and user-friendly combination products to market. Backed by a strong IP portfolio and a commitment to sustainability, Haselmeier aims to support pharmaceutical companies in enhancing patient therapy outcomes.

Portfolio of subcutaneous self-injection device platforms including pre-filled syringe-based autoinjectors (e.g., PiccoJect) and cartridge-based injection pens (e.g., D-Flex, Re-Vario) with capabilities for fixed/variable dose and in-pen reconstitution of lyophilized drugs.

Haselmeier competes in a crowded field of drug delivery device CDMOs, including major players like Ypsomed, SHL Medical, Gerresheimer, and Becton Dickinson. Its differentiation lies in its full-service approach, specific platform technologies like In-Pen Reconstitution, and its heritage as part of the medmix industrial group, emphasizing quality and partnership.